These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7484027)

  • 61. Recovery characteristics after early administration of anticholinesterases during intense mivacurium-induced neuromuscular block.
    Abdulatif M
    Br J Anaesth; 1995 Jan; 74(1):20-5. PubMed ID: 7880699
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].
    Barrio J; San Miguel G; García V; Pelegrín F
    Rev Esp Anestesiol Reanim; 2007; 54(7):399-404. PubMed ID: 17953333
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effects of three short-acting neuromuscular blocking agents on fast- and slow-contracting muscles of the cat.
    Marshall IG
    Eur J Pharmacol; 1973 Mar; 21(3):299-304. PubMed ID: 4267689
    [No Abstract]   [Full Text] [Related]  

  • 64. A study of the anticholinesterase and anticurare effects of some cholinesterase inhibitors.
    Barrow ME; Johnson JK
    Br J Anaesth; 1966 Jun; 38(6):420-31. PubMed ID: 5944020
    [No Abstract]   [Full Text] [Related]  

  • 65. Antagonism of vecuronium-induced neuromuscular blockade with edrophonium or neostigmine.
    Mirakhur RK; Gibson FM; Lavery GG
    Br J Anaesth; 1987 Apr; 59(4):473-7. PubMed ID: 2882768
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Recovery from mivacurium block with or without anticholinesterase following continuous infusion in obstetric patients.
    Jan GS; Tong WN; Chan AM; Hui TW; Lo JW
    Anaesth Intensive Care; 1996 Oct; 24(5):585-9. PubMed ID: 8909671
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dose-response relationships for edrophonium antagonism of mivacurium-induced neuromuscular block during N2O-enflurane-alfentanil anaesthesia.
    Marcotte J; Drolet P; Perreault L; Girard M
    Can J Anaesth; 1995 Oct; 42(10):879-83. PubMed ID: 8706197
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neuromuscular blocking and cardiovascular effects of Org 9487, a new short-acting aminosteroidal blocking agent, in anaesthetized animals and in isolated muscle preparations.
    Muir AW; Sleigh T; Marshall RJ; Pow E; Anderson KA; Booij LH; Hill DR
    Eur J Anaesthesiol; 1998 Jul; 15(4):467-79. PubMed ID: 9699106
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats.
    Wastila WB; Maehr RB; Turner GL; Hill DA; Savarese JJ
    Anesthesiology; 1996 Jul; 85(1):169-77. PubMed ID: 8694363
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neuromuscular blocking effects of cisatracurium and its antagonism with neostigmine in a canine model of autosomal-recessive centronuclear myopathy.
    Martin-Flores M; Paré MD; Campoy L; Gleed RD
    Br J Anaesth; 2015 Dec; 115(6):927-31. PubMed ID: 26582854
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Experimental pharmacology of atracurium dibesylate].
    Meistelman C; Lienhart A
    Ann Fr Anesth Reanim; 1985; 4(6):461-4. PubMed ID: 2418715
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dose-response relationships for edrophonium and neostigmine antagonism of pipecuronium-induced neuromuscular block.
    Naguib M; Abdulatif M
    Anesth Analg; 1994 Feb; 78(2):306-11. PubMed ID: 8311284
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia: A randomised controlled trial.
    Fuchs-Buder T; Baumann C; De Guis J; Guerci P; Meistelman C
    Eur J Anaesthesiol; 2013 Oct; 30(10):594-8. PubMed ID: 23803594
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium].
    Ebeling BJ; Keienburg T; Hausmann D; Apffelstaedt C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):304-8. PubMed ID: 8767244
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reversal of neuromuscular blockade in humans by neostigmine and edrophonium: a mathematical model.
    Verotta D; Kitts J; Rodriguez R; Coldwell J; Miller RD; Sheiner LB
    J Pharmacokinet Biopharm; 1991 Dec; 19(6):713-29. PubMed ID: 1687690
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neostigmine, pyridostigmine, and edrophonium as antagonists of pancuronium.
    Ferguson A; Egerszegi P; Bevan DR
    Anesthesiology; 1980 Nov; 53(5):390-4. PubMed ID: 7425377
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The influence of anticholinesterases on the neuromuscular block produced by suxamethonium.
    KOHN R; BOVET D
    J Pharm Pharmacol; 1956 May; 8(5):309-17. PubMed ID: 13320312
    [No Abstract]   [Full Text] [Related]  

  • 78. [Electromyographic studies of the supposed interference of Trasylol in neuromuscular block induced with curariform drugs].
    Manani G; Gritti G; Vecchini L; Manzin E; Merli GA
    Acta Anaesthesiol; 1968; 19():Suppl 9:1-21. PubMed ID: 4247861
    [No Abstract]   [Full Text] [Related]  

  • 79. Edrophonium and neostigmine for reversal of the neuromuscular blocking effect of vecuronium.
    Engbaek J; Ording H; Ostergaard D; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1985 Jul; 29(5):544-6. PubMed ID: 2863917
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Neostigmine and edrophonium for reversal of pipecuronium neuromuscular blockade.
    Abdulatif M; Naguib M
    Can J Anaesth; 1991 Mar; 38(2):159-63. PubMed ID: 1850665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.